We at MedCity News cover startups round the clock and have found they are a key contingent at our conferences.
With that aim, we are inviting patient engagement and corporate wellness startups to apply to our very first ENGAGE Pitch Perfect Contest, which will occur live at our ENGAGE conference in San Diego, Oct. 24. [The conference runs, Oct. 23 and Oct. 24 and will feature Bakul Patel, Associate Center Director of Digital Health, FDA but more on that down the road.]
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
So who can apply to be selected?
Patient engagement and employer wellness startups who have had at least one seed round of funding — could be a friends-and-family round — are invited to apply. Selected startups will pitch in two separate tracks to three judges each in front of the ENGAGE audience.
Entrepreneur pitches will be followed by a rapid Q&A session with the judges who will score their presentations. Winners will be announced shortly thereafter.
Getting instant feedback is highly valuable for startups who have to hone their presentation skills, and summarize their businesses as they prepare to pitch to investors. So if your company meets the following criteria, and you are interested in seeing how you stack up next to the most innovative healthcare startups nationally, you should apply now.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
- Companies must have completed at least one round of seed financing prior to the conference.
- Companies should currently be seeking or intend to seek additional rounds of capital within six to 12 months of the conference.
Click here to apply. The deadline is July 15 and judges will be announced soon. There is no application fee but selected startups will pay $495 to participate in the contest and attend the conference.
When completing the 2-page executive summary and the 500-character company description in the application form, please describe clearly what the unmet need in the marketplace is, what your value proposition is and how your product works. And if you have any clinical validation, please summarize it.
This will help investors screen your application based on the following criteria:
- Business Idea
- Market Opportunity
- Revenue Model
- Founder’s Experience
We have used this model successfully at our INVEST conference in Chicago in May where more than 45 startups in biopharma, medical devices, diagnostics and digital health tracks pitched to top notch investors from GE Ventures, Three Arch Venture Partners, H.I.G. Capital, OSF Venture Partners, Johnson & Johnson Innovation – JJDC and many more.
Here are the 2017 INVEST Pitch Perfect winners.
Again, here is the application form and the deadline to apply is July 31.
